The SARS-COV2 (COVID-19) Pandemic: What Clinicians should knew
نویسندگان
چکیده
منابع مشابه
“Letter to Editor” Should women postpone childbearing during the COVID-19 pandemic?
It is not clear whether women can decide to become pregnant during the COVID-19 pandemic or whether they are at risk, because examining the long-term consequences of the virus, especially in the first months of pregnancy, requires further time and research(1). The COVID-19 virus has not been found in the semen and testicles of men infected with the virus in the acute phase or during the recover...
متن کاملWhat Clinicians Should Know
Case presentation: A 36-year-old nonsmoking, normotensive South Asian man presented to the emergency department of a community hospital with retrosternal chest pain of 60 minutes’ duration. His 12-lead ECG demonstrated 10 mm of STsegment elevation in leads V2 through V6, and he received fibrinolytic therapy within 90 minutes of symptom onset. His pain resolved, but his ST segments only partiall...
متن کاملCOVID-19 Pandemic: What Can the West Learn From the East?
Differences in public health approaches to control the coronavirus disease 2019 (COVID-19) pandemic could largely explain substantial variations in epidemiological indicators (such as incidence and mortality) between the West and the East. COVID-19 revealed vulnerabilities of most western countries’ healthcare systems in their response to the ongoing public health crisi...
متن کاملHealth Inequalities during the COVID-19 Pandemic
Pandemics are associated with significant and destructive national and global impacts on health, economy, society, and security. COVID-19 pandemic has imposed adverse economic consequences on the whole population. This is while the elderly and those with comorbidities, the economically disadvantaged and ethnic minorities were at increased risk of viral infection. Moreover, the mortality rate an...
متن کاملBiosimilars: what clinicians should know.
Biosimilar medicinal products (biosimilars) have become a reality in the European Union and will soon be available in the United States. Despite an established legal pathway for biosimilars in the European Union since 2005 and increasing and detailed regulatory guidance on data requirements for their development and licensing, many clinicians, particularly oncologists, are reluctant to consider...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Afro-Egyptian Journal of Infectious and Endemic Diseases
سال: 2020
ISSN: 2090-7184
DOI: 10.21608/aeji.2020.93424